Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Dietary Specials gluten free white cake mix
090401030BZAAAK
|
Dietary Specials (G/F Mix) | Gluten free mixes | Nutrition and Blood | No data available |
|
Dietary Specials gluten free white loaf sliced
0904010H0CCAFAA
|
Dietary Specials (G/F Bread) | Gluten free breads | Nutrition and Blood | No data available |
|
Dietary Specials gluten free white long rolls
0904010H0CCAHAA
|
Dietary Specials (G/F Bread) | Gluten free breads | Nutrition and Blood | No data available |
|
Dietary Specials gluten free white mix
090401030BZAFAK
|
Dietary Specials (G/F Mix) | Gluten free mixes | Nutrition and Blood | No data available |
|
Dietary Specials gluten free white multigrain loaf sliced
0904010H0CCAIAA
|
Dietary Specials (G/F Bread) | Gluten free breads | Nutrition and Blood | No data available |
|
Diethylstilbestrol 500microgram / Lactic acid 5% pessaries
0702010L0AAACAC
|
Diethylstilbestrol (Vaginal) | Diethylstilbestrol | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Diethylstilbestrol 5mg tablets
0803010K0AAALAL
|
Diethylstilbestrol (Systemic) | Diethylstilbestrol | Malignant Disease and Immunosuppression | No data available |
|
Difflam-P 3% cream
1003020F0BBABAA
|
Difflam (Topical) | Benzydamine hydrochloride | Musculoskeletal and Joint Diseases | No data available |
|
Dificlir 200mg tablets
0501070ACBBAAAA
|
Dificlir | Fidaxomicin | Infections | No data available |
|
Dificlir 40mg/ml oral suspension
0501070ACBBABAB
|
Dificlir | Fidaxomicin | Infections | No data available |
|
Diflucan 200mg/100ml solution for infusion vials
0502010B0BBAEAE
|
Diflucan | Fluconazole | Infections | No data available |
|
Diflucan 50mg/25ml solution for infusion vials
0502010B0BBADAD
|
Diflucan | Fluconazole | Infections | No data available |
|
Diflucan One 150mg capsules
0502010B0BBAIAB
|
Diflucan | Fluconazole | Infections | No data available |
|
Diflunisal 250mg tablets
1001010D0AAAAAA
|
Diflunisal | Diflunisal | Musculoskeletal and Joint Diseases | No data available |
|
Diflunisal 500mg tablets
1001010D0AAABAB
|
Diflunisal | Diflunisal | Musculoskeletal and Joint Diseases | No data available |
|
Diftavax vacc inj 0.5ml pre-filled syringes
1404000F0BJAAAR
|
Diftavax | Diphtheria | Immunological Products and Vaccines | No data available |
|
Digamex 125microgram tablets
0201010F0BEABAE
|
Digamex | Digoxin | Cardiovascular System | No data available |
|
Digamex 250microgram tablets
0201010F0BEACAF
|
Digamex | Digoxin | Cardiovascular System | No data available |
|
Digamex 62.5microgram tablets
0201010F0BEAAAD
|
Digamex | Digoxin | Cardiovascular System | No data available |
|
Digestisan oral drops
190205500BCNFA0
|
Proprietary compound preparation BNF 1902055 | Other toiletry preparations | Other Drugs and Preparations | No data available |
|
Digestizyme capsules
091102000BBIIA0
|
Proprietary compound preparation BNF 0911020 | Other enzyme preparations 0911020 | Nutrition and Blood | No data available |
|
Digibind 38mg powder for solution for injection vials
0201010AABBAAAA
|
Digibind | Digoxin antibody | Cardiovascular System | No data available |
|
DigiFab 40mg powder for solution for infusion vials
0201010AABCAAAB
|
DigiFab | Digoxin antibody | Cardiovascular System | No data available |
|
Digitoxin 100microgram tablets
0201010D0AAAAAA
|
Digitoxin | Digitoxin | Cardiovascular System | No data available |
|
Digoxin 100micrograms/1ml solution for injection ampoules
0201010F0AAARAR
|
Digoxin | Digoxin | Cardiovascular System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.